Barclays lowered the firm’s price target on Westlake (WLK) to $135 from $175 and keeps an Overweight rating on the shares post the Q4 report. The firm says cyclical pressures are weighing on the company’s 2025 earnings expectations. However, Westlake’s “sustainable” cash flow is at a trough, unlike most of its chemical peers, and it has “ample balance sheet dry powder,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake Chemical’s Growth Potential and Attractive Valuation Support Buy Rating
- Westlake Chemical Partners Reports Steady 2024 Earnings
- Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
- Morning Movers: Domino’s Pizza slips following quarterly results
- Westlake Chemical Reports Record 2024 Financial Results